Musculoskeletal Orofacial Pain and Other Signs and Symptoms of Temporomandibular Disorders During Pregnancy: A Prospective Study

Aims: To describe the course of reported musculoskeletal pain in the temporomandibular region and other signs and symptoms of temporomandibular disorders (TMD) as well as psychological dis-tress over the course of pregnancy and 1 year postpartum. Methods: Women with musculoskeletal orofacial pain (n = 19) and pain-free comparison subjects (n = 16) in the first trimester of pregnancy were selected through records review from the popula-tion of a large health maintenance organization. Subjects com-pleted a self-administered questionnaire assessing pain, depression, and somatic symptoms; provided a sample of whole unstimulated saliva; and underwent a standardized clinical examination during the third, sixth, and ninth months of pregnancy and 1 year post-partum. Results: At baseline (third month of pregnancy), 16 of the 19 patients with musculoskeletal orofacial pain met criteria for an RDC/TMD diagnosis. Reported musculoskeletal orofacial pain diminished significantly during the second or third trimester of pregnancy and increased again postpartum. Measures of mandibu-lar opening increased over pregnancy in both cases and compari-son subjects and remained high postpartum. Depression and somatic symptoms changed little over the course of pregnancy but were substantially lowered at 1 year postpartum for both groups. As expected, subjects with pain had higher levels of palpation pain, diminished mandibular range of motion, and higher levels of psychological distress compared to subjects without orofacial pain. Conclusion: Musculoskeletal orofacial pain and related symptoms appear to improve over the course of pregnancy. This improvement occurs in the presence of increased joint laxity and is not paralleled by improvements in psychological distress. Thus, it was concluded that the improvement in pain is most likely associ-ated with the dramatic hormonal changes occurring during preg-nancy.

hormones; pain; pregnancy; psychological distress; temporomandibular disorders

1. Carlsson G, LeResche L. Epidemiology of temporo-mandibular disorders. In: Sessle BJ, Bryant PS, Dionne RA (eds). Temporomandibular Disorders and Related Pain Conditions, Progress in Pain Research and Management, vol 4. Seattle: IASP Press, 1995:211–226.

2. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997;8:291–305.

3. Drangsholt M, LeResche L. Temporomandibular disorder pain. In: Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M (eds). Epidemiology of Pain. Seattle: IASP Press, 1999:203–233.

4. Dao TTT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169–184.

5. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of tem-poromandibular disorder pain. Pain 1997;69:153–160.

6. Abubaker AO, John F, Sotereanos GC, Patterson G, Jenosky J. Prevalence of female sex hormone use by female TMJ patients [abstract]. J Dent Res 1992;71(spe-cial issue):259.

7. Marbach JJ, Lennon MC, Dohrenwend BP. Candidate risk factors for temporomandibular pain and dysfunction syndrome: Psychosocial, health behavior, physical illness and injury. Pain 1988;34:139–151.

8. Hatch JP, Rugh JD, Sakai S, Saunders MJ. Is the use of exogenous estrogen associated with temporomandibular signs and symptoms? J Am Dent Assoc 2001; 132:319–326.

9. Huang GJ, Gansky SA. This study reports no relationship between exogenous estrogen and temporomandibular disorders. J Evid Based Dent Pract 2001;1:191–193.

10. Brynhildsen JO, Björs E, Skarsgård C, Hammar ML. Is hormone replacement therapy a risk factor for low back pain among postmenopausal women? Spine 1998;7:809–813.

11. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253–261.

12. Bodnar RJ, Romero M, Kramer E. Organismic variables and pain inhibition: Roles of gender and aging. Brain Res Bull 1988;21:947–953.

13. Mogil JS, Sternberg WF, Kest B, Marek P, Liebeskind JC. Sex differences in the antagonism of swim stress–induced analgesia: Effects of gonadectomy and estrogen replace-ment. Pain 1993;53:17–25.

14. Sternberg WF, Mogil JS, Kest B, Page GG, Leong Y, Yam V, Liebeskind JC. Neonatal testosterone exposure influences neurochemistry of non-opioid swim stress-induced analgesia in adult mice. Pain 1995;63:321–326.

15. Speroff L, Glass RH, Kase NG. Regulation of the menstrual cycle. In: Clinical Gynecologic Endocrinology and Infertility, ed 5. Baltimore: Williams & Wilkins, 1994:183–220.

16. Hofmann GE. Hormones of pregnancy. In: Knobil E, Neill JD (eds). Encyclopedia of Reproduction. San Diego: Academic Press, 1998;2:670–680.

17. Goolkasian P, Rimer BA. Pain reactions in pregnant women. Pain 1984;20:87–95.

18. Dawson-Basoa ME, Gintzler AR. Estrogen and proges-terone activate spinal kappaopiate receptor analgesic mechanisms. Pain 1996;64:169–177.

19. Dworkin SF, LeResche L (eds). Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

20. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50:133–149.

21. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: A study in construct validation. J Clin Psychol 1977;33:981–989.

22. Read GF. Hormones in saliva. In: Tenovuo JO (ed). Human Saliva: Clinical Chemistry and Microbiology, vol 2. Boca Raton, FL: CRC Press, 1989:147–176.

23. Gann PH, Giovanazzi S, Van Horn L, Branning A, Chatterton RT Jr. Saliva as a medium for investigating intra- and interindividual differences in sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2001;10:59–64.

24. Bourque J, Sulon J, Demey-Ponsart E, Sodoyez JC, Gaspard U. A simple, direct radioimmunoassay for salivary progesterone determination during the menstrual cycle. Clin Chem 1986;32:948–951.

25. Chearskul S, Visutakul P. Non-invasive hormonal analysis for ovulation detection. J Med Assoc Thai 1994;77: 177–186.

26. Delfs TM, Klein S, Fottrell P, Naether OG, Leidenberger FA, Zimmermann RC. 24-hour profiles of salivary progesterone. Fertil Steril 1994;62:960–966.

27. Walker RF, Read GF, Riad-Fahmy D, Griffiths K. The assessment of ovarian function by the radioimmunoassay of estradiol-17β in saliva. In: Read GF, Riad-Fahmy D, Walker RF, Griffiths K (eds). Immunoassays of Steroids in Saliva. Cardiff, Wales: Alpha Omega, 1984:155–164.

28. Von Korff M, Dworkin SF, LeResche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173–183.

29. Hall K. Relaxin. J Reprod Fertil 1960;1:368–384.

30. Schauberger CW, Rooney BL, Goldsmith L, Shenton D, Silva PD, Schaper A. Peripheral joint laxity increases in pregnancy but does not correlate with relaxin levels. Am J Obstet Gynecol 1996;174:667–671.

31. Charlton WPH, Coslett-Charlton LM, Ciccotti MG. Correlation of estradiol in pregnancy and anterior cruciate ligament laxity. Clin Orthop Relat Res 2001;387: 165–170.

32. Marnach ML, Ramin KD, Ramsey PS, Song S-W, Stensland JJ, An K-N. Characterization of the relationship between joint laxity and maternal hormones in pregnancy. Obstet Gynecol 2003;101:331–335.

33. Westling L. Temporomandibular joint dysfunction and systemic joint laxity. Swed Dent J 1992;81(suppl):1–79.

34. Østensen M, Rugelsjøen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 1997;26:355–360.

35. Wilder RL. Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 1998;840:45–50.

36. Da Silva JAP, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992;11:189–194.

37. Ren K, Wei F, Dubner R, Murphy A, Hoffman GE. Progesterone attenuates persistent inflammatory hyperalgesia in female rats: Involvement of spinal NMDA receptor mechanisms. Brain Res 2000;865:272–277.

38. Ohrbach R, Dworkin SF. Five-year outcomes in TMD: Relationship of changes in pain to changes in physical and psychological variables. Pain 1998;74:315–326.

39. LeResche L. Research Diagnostic Criteria for TMD. In Fricton JR, Dubner R (eds). Orofacial Pain and Temporomandibular Disorders. Advances in Pain Research and Therapy, vol 21. New York: Raven Press, 1995: 189–203.

40. Epker J, Gatchel RJ. Prediction of treatment seeking behavior in acute TMD patients: Practical application in clinical settings. J Orofac Pain 2000;14:303–309.